Shockwave medical, inc. (SWAV)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-57,085

-51,109

-47,587

-44,808

-44,307

-41,102

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,508

1,337

1,088

933

826

700

0

0

0

Stock-based compensation

5,105

3,646

2,759

1,942

1,436

1,297

0

0

0

Amortization of right-of-use assets

1,064

944

0

0

0

-

-

-

-

Accretion of discount on available-for-sale securities

0

-

-

-

-

-

-

-

-

Loss on write down of fixed assets

-

67

0

0

0

-

-

-

-

Change in fair value of warrant liability

-

609

608

712

702

52

0

0

0

Amortization of debt issuance costs

485

436

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

3,872

4,527

2,896

3,539

2,797

2,211

0

0

0

Inventory

8,748

6,824

4,017

3,676

3,323

2,608

0

0

0

Prepaid expenses and other current assets

977

785

1,088

904

1,551

144

0

0

0

Other assets

-13

-41

909

852

793

917

0

0

0

Accounts payable

361

1,272

1,431

735

383

360

0

0

0

Accrued and other current liabilities

5,493

8,339

5,222

4,577

4,442

2,773

0

0

0

Lease liabilities

-847

-1,010

0

0

0

-

-

-

-

Other liabilities

-

-

-

-

-

98

0

0

0

Net cash used in operating activities

-57,881

-48,107

-45,351

-44,632

-44,503

-41,465

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of available-for-sale securities

0

-

-

-

-

-

-

-

-

Proceeds from maturities of available-for-sale securities

0

-

-

-

-

1,807

0

0

0

Purchase of property and equipment

8,052

3,817

3,138

2,351

2,086

1,981

0

0

0

Net cash provided by (used in) investing activities

-54,798

-59,543

-77,185

-85,135

-2,086

-174

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock upon initial public offering, net of issuance costs paid

-

100,547

0

0

0

-

-

-

-

Proceeds from issuance of common stock in private placement

-

10,000

0

0

0

-

-

-

-

Payments of offering costs

0

-

-

-

-

-

-

-

-

Principal payments of term loan

0

-

-

-

-

-

-

-

-

Net proceeds from term loan

0

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

3,150

2,206

1,049

368

280

426

0

0

0

Proceeds from issuance of common stock under employee stock purchase plan

0

-

-

-

-

-

-

-

-

Proceeds from warrant exercises

-

110

110

110

110

101

0

0

0

Net cash provided by financing activities

98,726

208,052

131,000

130,534

142,649

29,809

0

0

0

Net (decrease) increase in cash, cash equivalents and restricted cash

-13,953

100,402

8,464

767

96,060

-11,830

0

0

0

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid

510

534

508

414

270

156

0

0

0

Income tax paid

-

120

0

0

0

-

-

-

-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued on conversion of convertible preferred stock

-

152,806

0

0

0

-

-

-

-

Common stock issued upon net exercise of warrants

-

-

0

0

0

-

-

-

-

Common stock warrants issued on conversion of preferred stock warrants and the reclassification of the warrant liability

-

789

0

0

0

-

-

-

-

Issuance of Series A-1 convertible preferred stock on net exercise of warrants

-

-

-

-

-

316

0

0

0

Deferred offering costs included in accounts payable and accrued liabilities

-

-

-

-

0

-

-

-

-

Right-of-use asset obtained in exchange for lease liability

6,914

6,948

0

0

0

-

-

-

-

Property and equipment purchases included in accounts payable and accrued liabilities

3,995

52

79

142

74

55

0

0

0

Issuance of common stock warrants in connection with debt financing

-

-

-

-

-

104

0

0

0

Transfer of fixed assets to inventory

0

-

-

-

-

-

-

-

-